45 related articles for article (PubMed ID: 21257151)
21. Olopatadine: a drug for allergic conjunctivitis targeting the mast cell.
Leonardi A; Quintieri L
Expert Opin Pharmacother; 2010 Apr; 11(6):969-81. PubMed ID: 20307221
[TBL] [Abstract][Full Text] [Related]
22. Olopatadine 0.2% ophthalmic solution: the first ophthalmic antiallergy agent with once-daily dosing.
Abelson MB; Gomes PJ
Expert Opin Drug Metab Toxicol; 2008 Apr; 4(4):453-61. PubMed ID: 18433347
[TBL] [Abstract][Full Text] [Related]
23. Mast cell stabilization and anti-histamine effects of olopatadine ophthalmic solution: a review of pre-clinical and clinical research.
Rosenwasser LJ; O'Brien T; Weyne J
Curr Med Res Opin; 2005 Sep; 21(9):1377-87. PubMed ID: 16197656
[TBL] [Abstract][Full Text] [Related]
24. [Oral second generation antihistamines in allergic rhinitis].
Riechelmann H
Laryngorhinootologie; 2005 Jan; 84(1):30-41. PubMed ID: 15647976
[TBL] [Abstract][Full Text] [Related]
25. Olopatadine nasal spray for the treatment of seasonal allergic rhinitis in patients aged 6 years and older.
Roland PS; Ryan MW; Wall GM
Expert Opin Pharmacother; 2010 Jun; 11(9):1559-67. PubMed ID: 20482305
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive review of olopatadine: the molecule and its clinical entities.
Kaliner MA; Oppenheimer J; Farrar JR
Allergy Asthma Proc; 2010; 31(2):112-9. PubMed ID: 20406593
[TBL] [Abstract][Full Text] [Related]
27. A review of the use of olopatadine in allergic conjunctivitis.
McGill JI
Int Ophthalmol; 2004 May; 25(3):171-9. PubMed ID: 15847317
[TBL] [Abstract][Full Text] [Related]
28. [Pharmacological profile and clinical efficacy of olopatadine hydrochloride ophthalmic solution (Patanol 0.1% ophthalmic solution)].
Watanabe M; Kodama H; Hasegawa K; Itoh K
Nihon Yakurigaku Zasshi; 2007 Sep; 130(3):221-31. PubMed ID: 17878619
[No Abstract] [Full Text] [Related]
29. [Ophthalmology].
Takamura E
Nihon Rinsho; 2009 Nov; 67(11):2157-61. PubMed ID: 19899534
[TBL] [Abstract][Full Text] [Related]
30. Allergic ocular disorders: a spectrum of diseases.
Ehlers WH; Donshik PC
CLAO J; 1992 Apr; 18(2):117-24. PubMed ID: 1606674
[TBL] [Abstract][Full Text] [Related]
31. What is the most effective topical treatment for allergic conjunctivitis?
Schulz S; Adam P
J Fam Pract; 2015 May; 64(5):315, 21. PubMed ID: 26009742
[No Abstract] [Full Text] [Related]
32. Pharmacotherapy of allergic eye disease.
Manzouri B; Flynn TH; Larkin F; Ono SJ; Wyse R
Expert Opin Pharmacother; 2006 Jun; 7(9):1191-200. PubMed ID: 16732705
[TBL] [Abstract][Full Text] [Related]
33. Management of seasonal allergic conjunctivitis (SAC): current therapeutic strategies.
Anderson DF
Clin Exp Allergy; 2001 Jun; 31(6):823-6. PubMed ID: 11422145
[No Abstract] [Full Text] [Related]
34. Seasonal allergic conjunctivitis: overview and treatment update.
Joss JD; Craig TJ
J Am Osteopath Assoc; 1999 Jul; 99(7 Suppl):S13-8. PubMed ID: 10478515
[TBL] [Abstract][Full Text] [Related]
35. Second generation antihistamines: an update.
Sánchez-Borges M; Ansotegui IJ
Curr Opin Allergy Clin Immunol; 2019 Aug; 19(4):358-364. PubMed ID: 31169593
[TBL] [Abstract][Full Text] [Related]
36. Allergic eye disease.
Patel DS; Arunakirinathan M; Stuart A; Angunawela R
BMJ; 2017 Nov; 359():j4706. PubMed ID: 29097360
[No Abstract] [Full Text] [Related]
37. Update on ocular allergy treatment.
Bielory L
Expert Opin Pharmacother; 2002 May; 3(5):541-53. PubMed ID: 11996633
[TBL] [Abstract][Full Text] [Related]
38. Drug treatment of allergic conjunctivitis. A review of the evidence.
Ciprandi G; Buscaglia S; Cerqueti PM; Canonica GW
Drugs; 1992 Feb; 43(2):154-76. PubMed ID: 1372215
[TBL] [Abstract][Full Text] [Related]
39. Topical immunopharmacology of ocular allergies.
Bielory L; Kempuraj D; Theoharides T
Curr Opin Allergy Clin Immunol; 2002 Oct; 2(5):435-45. PubMed ID: 12582329
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
